Promyco Diagnostics

High-risk Pregnancy Assessment

Health Tech & Life Sciences
Non Active, Jan 2015
Pre-Funding Jerusalem Founded 2008
Total raised
Stage
Pre-Funding
Founded
2008
Headcount
6
HQ
Jerusalem
Sector
Health Tech & Life Sciences

About

Promyco Diagnostics has developed a simple and noninvasive serology diagnostic kit for the detection of urogenital Mycoplasma infection to assess women for theirrisk of developing pregnancy complications. Promyco Diagnostics has found a way to address the unique characteristics of the bacteria, mainly antigenic variation, that make it hard to develop an efficient serology diagnostic test. Promyco Diagnostics developed a new assay based on a patent-protected mixture of mycoplasmal components (antigens). This antigen cocktail was carefully selected from Mycoplasma isolated from patients with active inflammation, resulting in a highly sensitive and specific serology test.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Target customers
Healthcare & Life SciencesHealthcareConsumersDemographics & FamilyWomen
Business model
B2B

Tags

medical-devicesgynecologypregnancymedical-productswomen-healthdiagnostics